An overview of the prevalence and treatment of multiple myeloma

Multiple myeloma accounts for only 1.8% of cancers, but it is the second-most common blood cancer, with approximately 36,000 new cases diagnosed each year in the U.S., says Adams. The number of treatment choices has proliferated as new innovative therapies, such as the bispecific antibodies and chimeric antigen receptor (CAR) T-cell therapy, have been developed.